Neuronetics Other Liab from 2010 to 2024
| STIM Stock | USD 1.82 0.20 9.90% |
Other Liabilities | First Reported 2016-12-31 | Previous Quarter 829 K | Current Value 513 K | Quarterly Volatility 602.9 K |
Check Neuronetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuronetics' main balance sheet or income statement drivers, such as Interest Income of 3.3 M, Depreciation And Amortization of 1.8 M or Interest Expense of 4.2 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.0 or PTB Ratio of 1.94. Neuronetics financial statements analysis is a perfect complement when working with Neuronetics Valuation or Volatility modules.
Neuronetics | Other Liab |
Latest Neuronetics' Other Liab Growth Pattern
Below is the plot of the Other Liab of Neuronetics over the last few years. It is Neuronetics' Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neuronetics' overall financial position and show how it may be relating to other accounts over time.
| Other Liab | 10 Years Trend |
|
Other Liab |
| Timeline |
Neuronetics Other Liab Regression Statistics
| Arithmetic Mean | 916,300 | |
| Geometric Mean | 529,974 | |
| Coefficient Of Variation | 92.14 | |
| Mean Deviation | 733,680 | |
| Median | 746,100 | |
| Standard Deviation | 844,276 | |
| Sample Variance | 712.8B | |
| Range | 2.3M | |
| R-Value | 0.57 | |
| Mean Square Error | 522B | |
| R-Squared | 0.32 | |
| Significance | 0.03 | |
| Slope | 106,798 | |
| Total Sum of Squares | 10T |
Neuronetics Other Liab History
About Neuronetics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Neuronetics income statement, its balance sheet, and the statement of cash flows. Neuronetics investors use historical funamental indicators, such as Neuronetics's Other Liab, to determine how well the company is positioned to perform in the future. Although Neuronetics investors may use each financial statement separately, they are all related. The changes in Neuronetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Neuronetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Neuronetics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Neuronetics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Liabilities | 746.1 K | 1.2 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Neuronetics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Neuronetics Stock
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:Check out the analysis of Neuronetics Correlation against competitors. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 2.523 | Quarterly Revenue Growth 0.121 | Return On Assets (0.15) | Return On Equity (0.72) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.